Comparison of results with different left ventricular pacing leads
|
|
- Theresa Stafford
- 6 years ago
- Views:
Transcription
1 Europace (2008) 10, doi: /europace/eum241 Comparison of results with different left ventricular pacing leads Eyal Nof*, Osnat Gurevitz, Shemy Carraso, David Bar-Lev, David Luria, Sharona Bachar, Michael Eldar, and Michael Glikson* Heart Institute, Sheba Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Hashomer, Tel Aviv, Israel Received 19 May 2006; accepted after revision 12 October 2007; online publish-ahead-of-print 13 November 2007 KEYWORDS Left ventricular leads; Cardiac resynchronization therapy; Delivery systems Introduction Cardiac resynchronization therapy (CRT) is now an established form of therapy for patients with severe symptomatic systolic heart failure with a wide QRS (.120 ms) on ECG. Left ventricular (LV) pacing may be attained in a variety of ways, including direct access to the LV epicardial surface or via the transvenous approach using the coronary sinus (CS). The literature suggests that, in the majority of cases, lateral or posterolateral aspects of the left ventricle should be paced to gain maximal haemodynamic benefit. 1 3 Although the technique of transvenous CS lead implantation carries a lower risk than surgical epicardial lead implantation for the frail patient with heart failure, it nevertheless has several shortcomings and disadvantages. Despite increasing experience, the failure rate of CS lead implantation still averages up to 10% in most large studies. 4 7 Failures may result from the inability to cannulate the CS, coronary veins with small diameters or takeoff * Corresponding authors. Tel: þ address: ernof@netvision.net.il (E.N.); Tel: þ ; fax: þ address: mglikson@post.tau.ac.il (M.G.) Aims To compare different coronary sinus (CS) leads and delivery systems (DSs) for left ventricular pacing. Methods and results Delivery systems-related (including CS dissection and dislocations during sheath/ stylet removal) and lead-related (including failure to accomplish implantations and long-term malfunctions resulting in abandonment or repositioning/replacing of the lead) complications between systems and leads were compared. We used Medtronic (MDT) attain w DS (n ¼ 123) with over-the-wire (OTW) (4193, 4194) and stylet-driven (2187) leads, and Guidant (GDT) w DS (n ¼ 126) with Easytrak OTW leads (4513, 4518, and 4525). Coronory sinus dissection occurred in 6/123 (5%) cases using the MDT DS vs. 7/126 (6%) with GDT DS (P ¼ NS). Dislocations during sheath/stylet removal occurred in 8/123 cases (6%) with MDT DS, and in 8/126 (6%) with GDT DS (P ¼ NS). Failure to achieve successful implantation occurred in 6/32 (19%) of the 2187 leads, in 11/87(13%) of the 4193/4194 leads, in 7/94(7%) of the 4513/4518 leads, and in 4/29 (14%) of the 4525 leads (P ¼ NS). Long-term lead-related complications occurred in 5/32 (15%) of the 2187 leads, 19/80 (23%) of the 4193/4194 leads, 19/93 (20%) of the 4513/4518 leads, and 2/28 (7%) of the 4525 leads (P ¼ NS). Conclusion No significant differences in complication rates between systems and leads were observed. at acute angles, unacceptable pacing thresholds, and unstable positions with recurrent dislodgement or intractable diaphragmatic pacing, due either to phrenic nerve or direct diaphragmatic stimulation Even when apparently successful, a considerable number of implantations terminate with the lead in an anterior position in the great cardiac or anterior coronary vein, which is haemodynamically less beneficial than lateral or posterolateral positions. 1,12,13 Moreover, following an initially successful implantation, some patients with a CS lead lose their LV pacing due to late dislodgment, intractable diaphragmatic stimulation, or late threshold increase due to micro- or macro-dislodgment. 6,9,14 When taken together, acute and chronic failures result in a significant proportion of CRT recipients ending up with non-functional or ineffective LV pacing. To overcome these technical problems, several manufacturers have developed various CS leads with different structures, designs, and delivery systems (DSs). The two main types of CS LV leads are over-the-wire (OTW) leads, which have central lumen and stylet-driven leads. The lead is advanced via a DS on the basis of long sheaths that are introduced into the CS through which the lead is advanced. Following positioning of the lead, some DSs are pulled back Published on behalf of the European Society of Cardiology. All rights reserved. & The Author For permissions please journals.permissions@oxfordjournals.org.
2 36 E. Nof et al. around the lead to be removed, whereas others have to be split by cutting in order to facilitate the removal. In the current study, we sought to compare some of the different types of leads and DSs available with regard to short- and long-term performance and complications. Methods Patients This study composed of 249 consecutive patients who underwent transvenous CRT system implantation according to current guidelines at time of implantation, between January 2001 and January Leads Leads implanted in this study included: pre-shaped OTW leads (Medtronic 4193 þ 4194), pre-shaped stylet-driven cardiac vein leads with a hook-shaped distal configuration (Medtronic 2187) and OTW leads of straight unipolar, straight bipolar and pre-shaped curled bipolar design (Guidant Easytrak w models 4513, 4518, and 4525, respectively). Medtronic attain w DSs were used for all Medtronic leads and Guidant DSs for all Guidant lead implantations. For analysis of DS-related complications, all Medtronic and all Guidant leads were grouped together. For analysis of lead performance, Easytrak 1 and 2 leads (4513 and 4518, respectively) were grouped together due to similarity of design, and Guidant Easytrak w OTW type 3 leads (4525) were analysed separately in the LV lead performance analysis, due to their distinctive design. Implantations were performed in the pacemaker unit, using either local anaesthesia with conscious sedation or general anaesthesia, as required. All implantations were performed by one of three experienced operators (M.G., D.L., and O.G.). All three operators used all leads included in this specific study. The choice of system and lead was made according to availability at the day of implantation, rather than by the operator. Venous access was achieved by puncture of the axillary or subclavian vein. The right ventricular lead was positioned first, followed by the LV lead. Right atrial leads, when indicated, were implanted last, prior to removal of the LV DS. Complications at implantations and during 12-month follow-up were prospectively collected and retrospectively analysed in all patients using our CRT patient database. All patients were examined on the day following implantation, 2 weeks later and every 3 months thereafter. Our analysis included only complications that could be associated with either the DSs or the LV leads. Delivery systemrelated complications during implantation included CS dissection and/or failure to cannulate the CS and dislocations during sheath or stylet removal. Left ventricular lead-related complications during implantation included failure to accomplish successful LV lead implantation, associated with the need to switch to a different lead or to epicardial implantation, or to abort the LV lead implantation (excluding failures listed under DS-related complications). Complications during follow-up included LV lead dislocations proven by fluoroscopy, loss of LV capture or diaphragmatic pacing. Statistical analysis Continuous variables are expressed as mean + 1SD. Distributions of nominal data were compared using x 2 test. A value of P, 0.05 was considered as significant. Results There were no significant differences between the groups regarding baseline clinical characteristics (Table 1). The LV implantation site achieved with each lead was similar in all groups (Table 2). Peri-operative DS-related complications There were no significant differences between the two DSs regarding the occurrence of CS dissections (Table 3). Failure of CS cannulation occurred in six patients. In four of them, failure of cannulation was related to CS dissection. All CS dissections occurred with no haemodynamic compromise. Left ventricular lead dislocations during sheath or finishing wire removal occurred with similar frequency in both systems (Table 3). Of note, in one patient (with a Guidant DS w ) we had to abandon LV pacing due to such recurrent dislocations. In another patient (with a Medtronic Attain w DS) Table 1 Baseline clinical characteristics Medtronic attain w delivery system N ¼ 123 Guidant w delivery system N ¼ 126 P-Value Age (year) NS Gender (Male/female) (%) 83/17 88/12 Ischemic/idiopathic cardiomyopathy (%) 82/18 75/25 QRS width (ms) NS LVEF (%) NS LVEDD (mm) NS LVEF, left ventricular ejection fraction; LVEDD, left ventricular end diastolic dimension. Table 2 Left ventricular anatomic implantation sites achieved at the end of the implantation procedure (2187) N ¼ 32 (4193 þ 4194) N ¼ 87 (4513 þ 4518) N ¼ 94 (4525) N ¼ 29 P-value Implantation site Lateral/posterior lateral vein (%) Great cardiac vein (%)
3 Comparison of results with different LV pacing leads 37 the LV lead (4193) was replaced by a lead from a different manufacture not included in this study. Failure to accomplish LV lead implantation Overall, failure to accomplish successful LV lead implantation despite successful CS cannulation (excluding cases of lead dislodgement during guiding/sheath removal), occurred in 6/32 (19%) of the 2187 leads, 11/87(13%) of the 4193 þ 4194 leads, 7/94 (7%) of the Easytrak w leads (4513 þ 4518), and 4/29 (14%) of the Easytrak w lead 4525 (Table 4) (P ¼ 0.3). Of these, four cases of failure to implant a 2187 lead were managed by switching to a 4193 lead; four cases of failure to implant a 4193 lead were managed by switching to a 2187 lead, and three by switching to an Easytrak w 4518 lead. In one patient with a 4193 lead, it was necessary to re-operate with repositioning during the same session in the operating room. Three cases with failure to implant an Easytrak w 4518 lead were switched to 4525 leads and one to a 2187 lead. Three cases of failure to implant a 4525 lead were managed by switching to 4518 leads and one by switching to a 2187 lead. Three patients with failed implantation were referred for epicardial LV lead implantation via thoracotomy, and in five patients LV pacing was abandoned. The main reasons for failure were: inability to stabilize the lead in the CS tributary without recurrent dislocation, intractable phrenic stimulation, and the inability to reach a vein with acceptable thresholds (Table 4). Our final implant success rate (including the need to switch to a different lead) was 94% for the total study population of 249 patients. Long-term complications Follow-up was from 1 to 12 months with an average of months. Long-term complications included diaphragmatic stimulation and late lead dislocations. The rate of dislocations proven by fluoroscopy and/or by loss of capture was not significantly different between lead types (Table 5). Left Table 3 Peri-operative complications related to the delivery system Medtronic attain w delivery system N ¼ 123 Guidant delivery system w N ¼ 126 P-Value Coronary sinus dissections 6(5%) 7(6%) NS Failure to cannulate coronary sinus 4(3%) 2(2%) NS Acute left ventricular lead dislocations during removal of stylet/sheath 8(6%) 8(6%) NS Table 4 Lead-related reasons for failure to accomplish successful LV lead implantation 2187 N ¼ 32 (4193 þ 4194) N ¼ 87 (4513 þ 4518) N ¼ 94 Easytrak w Leads (4525) N ¼ 29 P-Value Failure to accomplish Diaphragmatic pacing successful left Recurrent dislocations ventricular lead implantation Failure to reach any vein with acceptable thresholds Total rate of failure 6 (19%) 11 (13%) 7 (7%) 4 (14%) 0.3 Successful switch to other lead/total rate of failure a 4/6 (67%) 8/11 (72%) 4/7 (57%) 4/4 (100%) a See text for details. Table 5 Long-term left ventricular lead-related complications (2187) N ¼ 32 (4193 þ 4194) N ¼ 80 (4513 þ 4518) N ¼ 93 (4525) N ¼ 28 P-Value Left ventricular lead dislocations 4 (12%) 2 LVP 6 (7%) 5 (5%) 0.2 Stopped 4 Re-operation 4 Re-operation 1 LVP Stopped 1 LVP Stopped 1 (3%) 13 (16%) 14 (15%) 2 (7%) 0.2 Diaphragmatic stimulation Intractable None 1 LVP Stopped 3 Reoperation diaphragmatic pacing 2 Re-operation Overall 5 (15%) 19 (23%) 19 (20%) 2 (7%) 0.3 LVP, left ventricular pacing.
4 38 E. Nof et al. ventricular pacing was abandoned in four patients due to lead dislocation, and in one patient due to diaphragmatic stimulation. There were no significant changes in the number of patients suffering from diaphragmatic stimulation (Table 5). In most cases (24/30, 80%) diaphragmatic stimulation was prevented by reprogramming pacemaker output and/or the polarities. Re-operation (either repositioning or replacement of the lead) was performed in seven patients with Easytrak w 4513 þ 4518 leads (four due to dislocation of the lead and three due to diaphragmatic stimulation), and in six patients with a 4193 þ 4194 leads (four due to dislocation of the lead and two due to diaphragmatic stimulation (Table 5). At 1 year follow-up re-operation was required in 5% and LV lead pacing was abandoned in a further 2% of patients. These results did not differ between different lead types. Discussion Despite considerable progress in lead design and technology over the last several years, lead technology for transvenous LV pacing is still far from being optimal. In this study of 249 patients, overall lead results were comparable to previous large series, 4,6,8 10 and demonstrated the current limitations of LV pacing via CS leads. At the start of a CRT implantation procedure, the physician is faced with a variety of different DSs and leads, which are not always interchangeable during the implantation process due to their specific sheath and connector sizes. The choice of lead at the beginning of an implantation is therefore more crucial than in traditional pacing, and comparison between the different systems may help in making this choice. We are not aware of any such previous comparative evaluation in the literature, and we therefore sought to compare four different leads, using two different DSs. CS cannulation and dissection failures occurred infrequently with all systems, and all CS dissections were benign, as previously reported 5,6,9 with the exception of a 2% reported CS perforation in one study 4 leading to haemodynamic compromise in a minority of these patients. Guiding sheath removal by the cutting of Attain systems is perceived by many operators as a problematic step predisposing to acute lead dislodgement. However, the rate of acute dislodgements during sheath/stylet/finishing wire removal at the conclusion of the procedure did not differ between the two DSs. Although it is conceivable that leads using the OTW technique and leads with smaller diameters may reach locations that are not accessible to larger, stiffer leads, we did not find significant failure rates or implant-related complications between leads using different techniques. Diaphragmatic pacing is a very troublesome phenomenon with LV pacing using CS leads, which may result from direct diaphragmatic stimulation or from capture of the phrenic nerve. In our study group, 3% of patients did not tolerate diaphragmatic pacing even after LV pacing thresholds were lowered, resulting in re-operation in 5, and cessation of LV pacing in another 1. These numbers are comparable with previous series. 6 Despite the relatively high level of diaphragmatic pacing, this problem was usually solved by programming at a lower output. Although numbers in this series are insufficient to demonstrate it, we have recently shown that bipolar leads (such as some of the Easytrak leads) may offer more flexibility in prevention of diaphragmatic stimulation by changing pacing location between the ring and the tip when this feature is available in the implanted device. 15 Re-operation, or the need to abandon LV pacing over time, occurred in 7% of patients in the current study, which is relatively low compared to previous reports, 4,6 and did not differ significantly among the different leads. It is important to emphasize that in some previous studies some of the leads used were older, which might account for the relative higher incidence of re-operation in one study 6 and CS dissection in another. 4 Furthermore, many older systems do not provide the ability of reprogramming polarity and therefore in cases of diaphragmatic stimulation or high thresholds the physician may have no choice but to re-operate. Another possibility is that implanters from different centres might have had different levels of experience with a procedure, which was relatively new during the early stages of the old studies. Limitations This is a retrospective analysis that carries all the weaknesses of a retrospective uncontrolled study, including lack of randomization between leads and lack of strict criteria for the decision to switch between leads and DSs. However, it is important to note that there was no selection bias between the systems, and the initial choice of the implanted system was based on the availability at the time of implantation, rather than on patient specific or procedure specific variables. Once a procedure was initiated with a certain system, the operator was often committed to leads of the same manufacturer (due to sheath and connector size and availability of products), thereby preventing efficient crossover between different designs that could have improved success rates. It is conceivable that different venous anatomies are better fitted to one particular lead than another. Operators should therefore encourage manufacturers to produce leads compatible with all systems, in order to provide optimal choice based on anatomy and problems encountered during the implantation procedure. The numbers in this series might not have been large enough to detect minor differences between leads and/or DSs, and therefore further larger trials are warranted. All the procedures were performed by three highly trained experienced operators, with the types of leads and DSs, as well as the rates of DSs and lead-related problems being equally distributed among all three operators. Additional parameters, such as procedure and fluoroscopy time, which could also have an impact on the choice of lead, were not available in some earlier implants in our database and therefore were not included in the current evaluation. Conclusions We have demonstrated that DSs and LV lead selection do not significantly affect overall short- and long-term results. The best results, however, can only be obtained when a complete variety of choice, without limitations of sheath sizes and connectors, is available for the individual implanter.
5 Comparison of results with different LV pacing leads 39 Acknowledgements The authors thank Miss. Vivienne York for her technical support. Conflict of interest: none declared. References 1. Gasparini M, Mantica M, Galimberti P, Bocciolone M, Genovese L, Mangiavacchi M et al. Is the left ventricular lateral wall the best lead implantation site for cardiac resynchronization therapy? Pacing Clin Electrophysiol 2003;26: Sogaard P, Hassager C. Tissue Doppler imaging as a guide to resynchronization therapy in patients with congestive heart failure. Curr Opin Cardiol 2004;19: Gras D, Mabo P, Tang T, Luttikuis O, Chatoor R, Pedersen AK et al. Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc. InSync Study. Pacing Clin Electrophysiol 1998;21: Abraham W, Fisher W, Smith A, Abraham WT, Fisher WG, Smith AL et al. MIRACLE Study Group. Cardiac resynchronization therapy in chronic heart failure. New Engl J Med 2002;346: Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C et al. Multisite stimulation in cardiomyopathies (MUSTIC) study investigators. Effects of multisite biventricular pacing with heart failure and intraventricular conduction delay. New Engl J Med 2001;344: Alonso C, Leclercq C, d Allonnes F, Pavin D, Victor F, Mabo P et al. Six year experience of transvenous left ventricular lead implantattion for permanent biventricular pacing in patients with advanced heart failure: technical aspects. Heart 2001;86: Oct. 7. Ollitrault J, Ritter P, Mabo P, Garrigue S, Grossin F, Lavergne T. Long term experience with a preshaped left ventricular pacing lead. PACE 2003;26: Schuchert A, Seidl K, Pfeiffer D, Oltmanns G, Danschel W, Aydin MA et al. Two year performance of a preshaped lead for left ventricular stimulation. Pace 2004;27: Daoud EG, Kalbfleisch SJ, Hummel JD, Weiss R, Augustini RS, Duff SB et al. Implantation techniques and chronic lead parameters of biventricular pacing dual chamber defibrillators. J Cardiovasc Electrophysiol 2002; 13: Kuhlkamp V, for the InSync 7272 ICD World Wide Investigators. Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy. J Am Coll Cardiol 2002;39: Ritter P, Gras D, Daubert C, On behalf of the MUSTIC Group. Implant success rate of the transvenous left ventricular lead in the MUSTIC trial (abstract). Pacing Clin Electrophysiol 2000;23: Butter C, Auricchio A, Stellbrink C, Fleck E, Ding J, Yu Y et al. The pacing therapy for chronic heart failure II study group. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation 2001;104: Hultgren HN, Craig E, Fujii J, Nakamura T, Biliosly J. Left bundle branch block and mechanical events of the cardiac cycle. Am J Cardiol 1983;52: Steinberg J, Derose J. The rationale for nontransvenous leads and cardiac resynchronization devices. Pacing Clin Electrophysiol 2003;26: Gurevitz O, Nof E, Carraso S, Luria D, Bar-Lev D, Eldar M et al. Programmable multiple pacing configurations help to overcome high left ventricular pacing thresholds and avoid phrenic nerve stimulation. Pacing Clin Electrophysiol 2005;28:
58 Marc-Alexander Ohlow, MD 1 ; Bernward Lauer, PhD 1 ; Michele Brunelli, PhD 2, Yunis Daralammouri, MD 1 ; J Christoph Geller, PhD 2 ;
www.ipej.org 58 Original Article The Use of a Quadripolar Left Ventricular Lead Increases Successful Implantation Rates in Patients with Phrenic Nerve Stimulation and/or High Pacing Thresholds Undergoing
More informationBiventricular Pacing: A Promising Therapeutic Alternative for Patients with Severe Congestive Heart Failure
September 2001 353 Biventricular Pacing: A Promising Therapeutic Alternative for Patients with Severe Congestive Heart Failure T. SZILI-TOROK, D. THEUNS, P. KLOOTWIJK, M.F. SCHOLTEN, G.P. KIMMAN, L.J.
More informationBiventricular pacing was proposed in 1994 as an adjuvant to medical treatment in patients
Heart 2001;86:405 410 405 Département de Cardiologie et Maladies Cardio-vasculaires, Centre Cardio-Pneumologique, Hôpital Pontchaillou, 2 rue Henri Le Guilloux, 35033 Rennes, France C Alonso C Leclercq
More informationEBR Systems, Inc. 686 W. Maude Ave., Suite 102 Sunnyvale, CA USA
Over 200,000 patients worldwide are estimated to receive a CRT device each year. However, limitations prevent some patients from benefiting. CHALLENGING PROCEDURE 5% implanted patients fail to have coronary
More informationCRT-D or CRT-P: HOW TO CHOOSE THE RIGHT PATIENT?
CRT-D or CRT-P: HOW TO CHOOSE THE RIGHT PATIENT? Alessandro Lipari, MD Chair and Department of Cardiology University of Study and Spedali Civili Brescia -Italy The birth of CRT in Europe, 20 years ago
More informationA Square Peg in a Round Hole: CRT IN PAEDIATRICS AND CONGENITAL HEART DISEASE
A Square Peg in a Round Hole: CRT IN PAEDIATRICS AND CONGENITAL HEART DISEASE Adele Greyling Dora Nginza Hospital, Port Elizabeth SA Heart November 2017 What are the guidelines based on? MADIT-II Size:
More informationHow to treat Cardiac Resynchronization Therapy complications? C. Leclercq Departement of Cardiology Centre Cardio-Pneumologique Rennes, France
How to treat Cardiac Resynchronization Therapy complications? C. Leclercq Departement of Cardiology Centre Cardio-Pneumologique Rennes, France Presenter Disclosure Information Christophe Leclercq, MD,
More informationCRT Implantation Techniques 부천세종병원순환기내과박상원
Cardiac Venous System and CRT Implantation Techniques 부천세종병원순환기내과박상원 Cardiac Resynchronization Therapy (CRT) Goal: Atrial synchronous biventricular pacing Transvenous approach for left ventricular lead
More informationAnodal Capture in Cardiac Resynchronization Therapy Implications for Device Programming
Anodal Capture in Cardiac Resynchronization Therapy Implications for Device Programming DAVID TAMBORERO,* LLUIS MONT,* ROBERTO ALANIS, ANTONIO BERRUEZO,* JOSE MARIA TOLOSANA,* MARTA SITGES,* BARBARA VIDAL,*
More informationBiventricular pacing (BVP) is effective in patients
Case Report 178 Right Ventricular Lead Ring Capture in Sequential Biventricular Pacing with Pseudo-bipolar Left Ventricular Lead Configuration: an Unwanted Effect Oruganti Sai Satish, MD, DM; Kuan-Hung
More informationThe Management of Heart Failure after Biventricular Pacing
The Management of Heart Failure after Biventricular Pacing Juan M. Aranda, Jr., MD University of Florida College of Medicine, Division of Cardiovascular Medicine, Gainesville, Florida Approximately 271,000
More informationGirish M Nair, Seeger Shen, Pablo B Nery, Calum J Redpath, David H Birnie
268 Case Report Cardiac Resynchronization Therapy in a Patient with Persistent Left Superior Vena Cava Draining into the Coronary Sinus and Absent Innominate Vein: A Case Report and Review of Literature
More informationBiventricular Pacing - Hemodynamic Benefit for Patients with Congestive Heart Failure
428 December 2000 Biventricular Pacing - Hemodynamic Benefit for Patients with Congestive Heart Failure K. MALINOWSKI Helios Clinics, Aue, Germany Summary Congestive heart failure afflicts a large and
More informationResearch Article. Open Access. Hai-Bo ZHANG 1, Xu MENG 1, Jie HAN 1, Yan LI 1, Ye ZHANG 2, Teng-Yong JIANG 3, Ying-Xin ZHAO 3, Yu-Jie Zhou 3
Journal of Geriatric Cardiology (2017) 14: 261 265 2017 JGC All rights reserved; www.jgc301.com Research Article Open Access Transvenous versus open chest lead placement for resynchronization therapy in
More informationG Lin, R F Rea, S C Hammill, D L Hayes, P A Brady
Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA Correspondence to: Dr Peter A Brady, MD, FRCP, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA; brady.peter@mayo.edu Accepted
More informationRobotically Assisted Left Ventricular Epicardial Lead Implantation for Biventricular Pacing
Journal of the American College of Cardiology Vol. 41, No. 8, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Science Inc. doi:10.1016/s0735-1097(03)00252-3
More informationInitial Clinical Experience With A Novel Left Ventricular Quadripolar Lead. Johannes Sperzel Kerckhoff Heart Center, Bad Nauheim, Germany
Initial Clinical Experience With A Novel Left Ventricular Quadripolar Lead Johannes Sperzel Kerckhoff Heart Center, Bad Nauheim, Germany Conflict of Interest - Disclosure Within the past 12 months, I have
More informationKey Words: Balloon Venoplasty of Subclavian Vein, Cardiac Resynchronisation Therapy. Case report
221 Case Report Balloon Venoplasty of Subclavian Vein and Brachiocephalic Junction to Enable Left Ventricular Lead Placement for Cardiac Resynchronisation Therapy Thanh Trung Phan, Simon James, Andrew
More informationPractical Approach to Implanting Left Ventricular Pacing Leads for Cardiac Resynchronization
100 TECHNIQUES AND TECHNOLOGY Editor: Hugh Calkins, M.D. Practical Approach to Implanting Left Ventricular Pacing Leads for Cardiac Resynchronization ANGEL R. LEÓN, M.D., DAVID B. DELURGIO, M.D., and FERNANDO
More informationFirst Implantation of the Triplos LV Three-Chamber Pacemaker: A Case-Report
January 2001 25 First Implantation of the Triplos LV Three-Chamber Pacemaker: A Case-Report T. LAWO, B. LEMKE, J. BARMEYER Department of Cardiology, BG Clinics Bergmannsheil, Ruhr University Bochum, Bochum,
More informationCardiac resynchronization therapy for mild-to-moderate heart failure
For reprint orders, please contact reprints@expert-reviews.com Cardiac resynchronization therapy for mild-to-moderate heart failure Expert Rev. Med. Devices 8(3), 313 317 (2011) Haran Burri Electrophysiology
More informationThe Effect of Concomitant Cardiac Resynchronization Therapy on Quality of Life in Patients with Heart Failure Undergoing Cardiac Surgery
Send Orders for Reprints to reprints@benthamscience.net 18 The Open Cardiovascular Medicine Journal, 2014, 8, 18-22 Open Access The Effect of Concomitant Cardiac Resynchronization Therapy on Quality of
More informationBiventricular pacing in patients with heart failure and intraventricular conduction delay: state of the art and perspectives.
European Heart Journal (2001) 23, 682 686 doi:10.1053/euhj.2001.2958, available online at http://www.idealibrary.com on Hotline Editorial Biventricular pacing in patients with heart failure and intraventricular
More informationBiventricular vs. left univentricular pacing in heart failure: rationale, design, and endpoints of the B-LEFT HF study
Europace (2006) 8, 76 80 doi:10.1093/europace/euj020 Biventricular vs. left univentricular pacing in heart failure: rationale, design, and endpoints of the B-LEFT HF study Christophe Leclercq 1 *, Gerardo
More informationImplantation of a biventricular implantable cardioverter-defibrillator guided by an electroanatomic mapping system
Europace (2012) 14, 107 111 doi:10.1093/europace/eur250 CLINICAL RESEARCH Pacing and Resynchronization Therapy Implantation of a biventricular implantable cardioverter-defibrillator guided by an electroanatomic
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,900 116,000 120M Open access books available International authors and editors Downloads Our
More informationBiventricular Pacing Using Two Pacemakers and Triggered VVT Mode in Patients With Atrial Fibrillation and Congestive Heart Failure: A Case Report
2 VVT 1 Biventricular Pacing Using Two Pacemakers and Triggered VVT Mode in Patients With Atrial Fibrillation and Congestive Heart Failure: A Case Report Youhei Toshiyuki Kazuaki Shinichi Yasuyuki Toshiaki
More informationHis Bundle Pacing in Bundle Branch Block May 11, 2017
His Bundle Pacing in Bundle Branch Block May 11, 2017 Gopi Dandamudi, MD FHRS System Medical Director, IUH Cardiac EP Program Director, IUH Atrial Fibrillation Center Assistant Professor of Clinical Medicine
More informationReduction of Mitral Regurgitation by Endocardial Right Ventricular Bifocal Pacing in Cases of Dilated Cardiomyopathy
June 2000 233 Reduction of Mitral Regurgitation by Endocardial Right Ventricular Bifocal Pacing in Cases of Dilated Cardiomyopathy J. C. PACHON M., R. N. ALBORNOZ, E. I. PACHON M., V. M. GIMENES, J. PACHON
More informationVentricular Resynchronization by Left Ventricular Stimulation in Patients with Refractory Dilated Cardiomyopathy
October 2000 353 Ventricular Resynchronization by Left Ventricular Stimulation in Patients with Refractory Dilated Cardiomyopathy S. S. GALVÃO JR, C. M. B. BARCELOS, J. T. M. VASCONCELOS, M. J. G. ARNEZ,
More informationIndications for and Prediction of Successful Responses of CRT for Patients with Heart Failure
Indications for and Prediction of Successful Responses of CRT for Patients with Heart Failure Edmund Keung, MD Clinical Chief, Cardiology Section San Francisco VAMC October 25, 2008 Presentation Outline
More informationGabor Z. Duray, Carsten W. Israel, Dimitrij Pajitnev, and Stefan H. Hohnloser*
Europace (2008) 10, 48 52 doi:10.1093/europace/eum259 Upgrading to biventricular pacing/defibrillation systems in right ventricular paced congestive heart failure patients: prospective assessment of procedural
More informationLeft Ventricular Pacing. Is it Enough?
Research Journal of Medicine and Medical Sciences, 4(1): 89-99, 2009 2009, INSInet Publication Left Ventricular Pacing. Is it Enough? Ashraf Wadie, MD, Ahmed Abdel Aziz, MD, Gamal Hamed, MD, Dalia Ragab,
More informationCardiac resynchronization therapy (CRT) with biventricular
Improvement of Left Ventricular Function After Cardiac Resynchronization Therapy Is Predicted by Tissue Doppler Imaging Echocardiography Martin Penicka, MD; Jozef Bartunek, MD, PhD; Bernard De Bruyne,
More informationUpgrade to Resynchronization Therapy. Saeed Oraii MD, Cardiologist Interventional Electrophysiologist Tehran Arrhythmia Clinic May 2016
Upgrade to Resynchronization Therapy Saeed Oraii MD, Cardiologist Interventional Electrophysiologist Tehran Arrhythmia Clinic May 2016 Event Free Survival (%) CRT Cardiac resynchronization therapy (CRT)
More informationEndurance and Performance of Two Different Concepts for Left Ventricular Stimulation with Bipolar Epicardial Leads in Long-Term Follow-Up
70 Original Cardiovascular/Society Paper Endurance and Performance of Two Different Concepts for Left Ventricular Stimulation with Bipolar Epicardial Leads in Long-Term Follow-Up H. Burger 1 J. Kempfert
More informationComparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure
HOT TOPIC Cardiology Journal 2010, Vol. 17, No. 6, pp. 543 548 Copyright 2010 Via Medica ISSN 1897 5593 Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart
More informationImplantation-Related Complications of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy Devices
Journal of the American College of Cardiology Vol. 58, No. 10, 2011 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2011.06.007
More informationCardiac resynchronization therapy (CRT) reduces symptoms
Epicardial left ventricular lead placement for cardiac resynchronization therapy: Optimal pace site selection with pressure-volume loops A. L. A. J. Dekker, PhD a B. Phelps, MD a B. Dijkman, MD, PhD b
More informationHow to Maximize CRT Response?
How to Maximize CRT Response? Chu-Pak Lau, MD Honorary Clinical Professor Department of Medicine University of Hong Kong Queen Mary Hospital Hong Kong 1 100% 1/3 of Patients Are Non-Responders of CRT 90%
More informationLONGITUDINAL SURVEILLANCE REGISTRY OF ACUITY SPIRAL LEAD
CLINICAL SUMMARY LONGITUDINAL SURVEILLANCE REGISTRY OF ACUITY SPIRAL LEAD CAUTION: Federal law restricts this device to sale by or on the order of a physician trained or experienced in device implant and
More informationLeadless Pacing. Osama Diab Assistant Prof. of Cardiology Ain Shams University Egypt
Leadless Pacing Osama Diab Assistant Prof. of Cardiology Ain Shams University Egypt The weakest link in Pacemaker system the lead. The more the leads the more the complications Dislodgement Fracture Insulation
More informationCardiac resynchronization therapy (CRT) delivered through biventricular
PHARMACOMECHANICAL APPROACH TO CHF TREATMENT Cardiac Resynchronization Therapy Devices: Patient Management and Follow-Up Strategies Angel R. Leon, MD, FACC Emory Crawford Long Hospital, Division of Cardiology,
More informationIndications and Technique
Robotic LV Epicardial Lead Placement: Indications and Technique Sandhya K. Balaram, M.D., Ph.D. Division of Cardiothoracic Surgery St. Luke s-roosevelt Hospital Center Assistant Professor of Clinical Surgery
More informationSupplemental Material
Supplemental Material 1 Table S1. Codes for Patient Selection Cohort Codes Primary PM CPT: 33206 or 33207 or 33208 (without 33225) ICD-9 proc: 37.81, 37.82, 37.83 Primary ICD Replacement PM Replacement
More informationGabor Z. Duray, Joern Schmitt, Sule Cicek-Hartvig, Stefan H. Hohnloser*, and Carsten W. Israel
Europace (2009) 11, 297 302 doi:10.1093/europace/eun322 CLINICAL RESEARCH Implantable Cardioverter-Defibrillators Complications leading to surgical revision in implantable cardioverter defibrillator patients:
More informationCardiac Resynchronization in Patients With Atrial Fibrillation
Journal of the American College of Cardiology Vol. 52, No. 15, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.06.043
More informationFor several years, numerous clinical trials have shown
ORIGINAL ARTICLES: Robotic-Enhanced Biventricular Resynchronization: An Alternative to Endovenous Cardiac Resynchronization Therapy in Chronic Heart Failure Jean-Luc Jansens, MD, Maurice Jottrand, MD,
More informationBiventricular Pacemakers Sensing
Biventricular Pacemakers Sensing Sergio Dubner Director Arrhythmias and Electrophisiology Service, Clinica y Maternidad Suizo-Argentina, Buenos Aires, Argentina Left ventricular pacemaker lead technology
More informationBiventricular Pacemaker. Health Technology Scientific Literature Review
Biventricular Pacemaker Health Technology Scientific Literature Review Completed February 2003 Disclaimer This health technology scientific literature review was prepared by the Medical Advisory Secretariat,
More informationChapter 25. N Ajmone Marsan, G B Bleeker, R J van Bommel, C JW Borleffs, M Bertini, E R Holman, E E van der Wall, M J Schalij, and J J Bax
Chapter 25 Cardiac resynchronization therapy in patients with ischemic versus nonischemic heart failure: Differential effect of optimizing interventricular pacing interval N Ajmone Marsan, G B Bleeker,
More informationImplantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety
Europace (2007) 9, 516 522 doi:10.1093/europace/eum080 Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety D. Gras 1,D.Böcker 2, M. Lunati
More informationDialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy
Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy Evan Adelstein, MD, FHRS John Gorcsan III, MD Samir Saba, MD, FHRS
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/19036 holds various files of this Leiden University dissertation. Author: Bommel, Rutger Jan van Title: Cardiac resynchronization therapy : determinants
More informationT he use of biventricular pacing in patients with heart failure
859 CARDIOVASCULAR MEDICINE Colour tissue velocity imaging can show resynchronisation of longitudinal left ventricular contraction pattern by biventricular pacing in patients with severe heart failure
More informationBSH Annual Autumn Meeting 2017
BSH Annual Autumn Meeting 2017 Presentation title: The Development of CRT Speaker: John GF Cleland Conflicts of interest: I have received research support and honoraria from Biotronik, Boston Scientific,
More informationNoninvasive Assessment of the Biventricular Pacing System
REVIEW Noninvasive Assessment of the Biventricular Pacing System Jonathan S. Steinberg, M.D., Parimal B. Maniar, M.D., Steven L. Higgins, M.D., Sherie L. Whiting, R.N., David B. Meyer, M.D., Sergio Dubner,
More informationPredictive Power of the Baseline QRS Complex Duration for Clinical Response to Cardiac Resynchronisation Therapy
CARDIAC MARKERS ORIGINAL RESEARCH Predictive Power of the Baseline QRS Complex Duration for Clinical Response to Cardiac Resynchronisation Therapy Ali Kazemisaeid, MD, Ali Bozorgi, MD, Ahmad Yamini Sharif,
More information7 Cardiac Resynchronization
7 Cardiac Resynchronization Therapy Daniel Frisch, MD and Peter J. Zimetbaum, MD CONTENTS PATHOPHYSIOLOGY OF DYSSYNCHRONY AND DEFINITIONS IMAGING MODALITIES TO IDENTIFY PATIENTS CLINICAL EVIDENCE HARDWARE
More informationLong-Term Prognosis After Cardiac Resynchronization Therapy Is Related to the Extent of Left Ventricular Reverse Remodeling at Midterm Follow-Up
Journal of the American College of Cardiology Vol. 53, No. 6, 29 29 by the American College of Cardiology Foundation ISSN 735-97/9/$36. Published by Elsevier Inc. doi:.6/j.jacc.28..32 Cardiac Resynchronization
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure (review
More informationPredictive Power of the Baseline QRS Complex Duration for Clinical Response to Cardiac Resynchronisation Therapy
CARDIAC RESYNCHRONISATION THERAPY ORIGINAL ARTICLE Predictive Power of the Baseline QRS Complex Duration for Clinical Response to Cardiac Resynchronisation Therapy Ali Kazemisaeid, MD, Ali Bozorgi, MD,
More informationCardiac Resynchronisation Therapy for all Patients Requiring Ventricular Pacing
Cardiac Resynchronisation Therapy for all Patients Requiring Ventricular Pacing Philippe Mabo University Hospital, Rennes, France ESC Congress 2010, Stockholm 29 Aug 2010 Which Patients? Candidate for
More information8/8/2011. CARDIAC RESYCHRONIZATION THERAPY for Heart Failure. Case Presentation. Case Presentation
CARDIAC RESYCHRONIZATION THERAPY for Heart Failure James Taylor, DO, FACOS Cardiothoracic and Vascular surgery San Angelo Community Medical Center San Angelo, TX Case Presentation 64 year old female with
More informationCardiac Resynchronization Therapy: Improving Patient Selection and Outcomes
The Journal of Innovations in Cardiac Rhythm Management, 3 (2012), 899 904 DEVICE THERAPY CLINICAL DECISION MAKING Cardiac Resynchronization Therapy: Improving Patient Selection and Outcomes GURINDER S.
More informationPositive Results with a New Screw-in Electrode with Isolated Screw and Fractal Coating of the Ring: the RETROX Electrode in the Atrial Position
314 June 1999 Positive Results with a New Screw-in Electrode with Isolated Screw and Fractal Coating of the Ring: the RETROX Electrode in the Atrial Position M. BOKERN Waterland Ziekenhuis, Purmerend,
More informationInitial Experience With an Implantable Cardioverter-Defibrillator Incorporating Cardiac Resynchronization Therapy
Journal of the American College of Cardiology Vol. 39, No. 5, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(01)01819-8
More informationBrian Olshansky, MD, FHRS,* John D. Day, MD, FHRS, Renee M. Sullivan, MD,* Patrick Yong, MSEE, Elizabeth Galle, MS, Jonathan S. Steinberg, MD, FHRS
Does cardiac resynchronization therapy provide unrecognized benefit in patients with prolonged PR intervals? The impact of restoring atrioventricular synchrony: An analysis from the COMPANION Trial Brian
More informationLong-term Preservation of Left Ventricular Function and Heart Failure Incidence with Ablate and Pace Therapy Utilizing Biventricular Pacing
The Journal of Innovations in Cardiac Rhythm Management, 3 (2012), 976 981 HEART FAILURE RESEARCH ARTICLE Long-term Preservation of Left Ventricular Function and Heart Failure Incidence with Ablate and
More informationHigh prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration
54 CARDIOVASCULAR MEDICINE High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration C-M Yu, H Lin, Q Zhang, J E Sanderson...
More informationEffect of cardiac resynchronization therapy on the incidence of electrical storm
International Journal of Cardiology 143 (2010) 330 336 www.elsevier.com/locate/ijcard Effect of cardiac resynchronization therapy on the incidence of electrical storm Peter Nordbeck, Bernhard Seidl, Beatrix
More informationJournal of the American College of Cardiology Vol. 52, No. 23, by the American College of Cardiology Foundation ISSN /08/$34.
Journal of the American College of Cardiology Vol. 52, No. 23, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2008.08.027
More informationEuropace Advance Access published January 28, 2008
Europace doi:10.1093/europace/eum297 Europace Advance Access published January 28, 2008 Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients
More informationJournal of the American College of Cardiology Vol. 50, No. 13, by the American College of Cardiology Foundation ISSN /07/$32.
Journal of the American College of Cardiology Vol. 50, No. 13, 2007 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2007.04.096
More informationDefibrillation threshold testing should no longer be performed: contra
Defibrillation threshold testing should no longer be performed: contra Andreas Goette St. Vincenz-Hospital Paderborn Dept. of Cardiology and Intensive Care Medicine Germany No conflict of interest to disclose
More informationThis is What I do to Improve CRT Response for CRT Non-Responders
This is What I do to Improve CRT Response for CRT Non-Responders Michael R Gold, MD, PhD Medical University of South Carolina Charleston, SC Disclosures: Steering Committees (unpaid) and Clinical Trials,
More informationCheuk-Man Yu, MD, Wing-Hong Fung, MRCP, Hong Lin, BM, MM, Qing Zhang, BM, MM, John E. Sanderson, MD, and Chu-Pak Lau, MD
Predictors of Left Ventricular Reverse Remodeling After Cardiac Resynchronization Therapy for Heart Failure Secondary to Idiopathic Dilated or Ischemic Cardiomyopathy Cheuk-Man Yu, MD, Wing-Hong Fung,
More informationTechnical option of surgical approach for trouble-shooting
JHRS Corner Device and lead trouble-shooting - standard strategy and technical option - Technical option of surgical approach for trouble-shooting Katsuhiko IMAI Department of Cardiovascular surgery, Hiroshima
More informationA Randomized Comparison of Triple-Site Versus Dual-Site Ventricular Stimulation in Patients With Congestive Heart Failure
Journal of the American College of Cardiology Vol. 51, No. 15, 2008 2008 by the American College of Cardiology Foundation ISSN 0735-1097/08/$34.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2007.11.074
More informationCover Page. The handle holds various files of this Leiden University dissertation
Cover Page The handle http://hdl.handle.net/1887/29823 holds various files of this Leiden University dissertation Author: Bie, M.K. de Title: Prevention of sudden cardiac death in patients with chronic
More informationPacing Lead Implant Testing. Document Identifier
Pacing Lead Implant Testing 1 Objectives Upon completion of this presentation, the participant should be able to: Name the two primary surgical options for implanting pacing leads Describe three significant
More informationIntroduction. Case Report ECG & EP CASES ABSTRACT
Successful extraction of an implantable cardioverter-defibrillator lead in a patient with pocket infection via the femoral approach with a basket snare Jin-Bae Kim, MD, PhD. Cardiology Division, Department
More informationPediatric Pacemaker Implantation Endocardial or Epicardial
Pediatric Pacemaker Implantation Endocardial or Epicardial HAITHAM BADRAN, MD, FEHRA CONSULTANT OF INTERVENTIONAL CARDIOLOGY CONSULTANT OF CARDIAC PACING AND ELECTROPHYSIOLOGY LECTURER OF CARDIOLOGY AIN
More information14ο Βορειοελλαδικό Καρδιολογικό Συνέδριο ΚΕΒΕ Βηματοδότηση: Νεότερες εξελίξεις Προοπτικές
14ο Βορειοελλαδικό Καρδιολογικό Συνέδριο ΚΕΒΕ Βηματοδότηση: Νεότερες εξελίξεις Προοπτικές Α.Γ. Κατσίβας Συντονιστής Διευθυντής, Α Καρδιολογική Κλινική, ΓΝΑ «Κοργιαλένειο-Μπενάκειο Ε.Ε.Σ» BRADY - ARRHYTHMIA
More informationTriple-site biventricular pacing in patients undergoing cardiac resynchronization therapy: a feasibility study
Europace (2007) 9, 762 767 doi:10.1093/europace/eum140 Triple-site biventricular pacing in patients undergoing cardiac resynchronization therapy: a feasibility study Radosław Lenarczyk*, Oskar Kowalski,
More informationPACEMAKER INTERPRETATION AND DEVICE MANAGEMENT PART I
1 PACEMAKER INTERPRETATION AND DEVICE MANAGEMENT PART I Cynthia Webner DNP, RN, CCNS, CCRN-CMC Karen Marzlin DNP, RN, CCNS, CCRN-CMC 2 PROFESSIONAL NURSING PRACTICE CAN ONLY ADVANCE AS MUCH AS INDIVIDUAL
More informationBiventricular Pacemakers (Cardiac Resynchronization Therapy) for the Treatment of Heart Failure
Biventricular Pacemakers (Cardiac Resynchronization Therapy for the Treatment of Heart Failure 2.02.10 Biventricular Pacemakers (Cardiac Resynchronization Therapy for the Treatment of Heart Failure Policy
More informationTransvenous Pacemaker Procedures
Cardiology: Pacemaker and Defibrillator Coding Presented By: Moderate Sedation 2017 99151 : under age 5, initial 15 minutes by MD performing intervention 99152: age 5 or older, initial 15 minutes by MD
More informationCardiac Resynchronization Therapy Optimization Using Trans Esophageal Doppler in Patients with Dilated Cardiomyopathy
Med. J. Cairo Univ., Vol. 82, No. 2, March: 17-22, 2014 www.medicaljournalofcairouniversity.net Cardiac Resynchronization Therapy Optimization Using Trans Esophageal Doppler in Patients with Dilated Cardiomyopathy
More informationDOI: /
The Egyptian Journal of Hospital Medicine (Apr. 2015) Vol. 59, Page 167-171 Optimization of Coronary Sinus Lead Position in Cardiac Resynchronization Therapy guided by Three Dimensional Echocardiography
More informationCardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides
Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Colette Seifer MB(Hons) FRCP(UK) Associate Professor, University of Manitoba, Cardiologist, Cardiac Sciences Program, St Boniface Hospital
More informationHow to Approach the Patient with CRT and Recurrent Heart Failure
How to Approach the Patient with CRT and Recurrent Heart Failure Byron K. Lee MD Associate Professor of Medicine Electrophysiology and Arrhythmia Section UCSF Update in Electrocardiography and Arrhythmias
More informationOriginal Article Long-Term Performance of Modern Coronary Sinus Leads in Cardiac Resynchronization Therapy
112 Original Article Long-Term Performance of Modern Coronary Sinus Leads in Cardiac Resynchronization Therapy Jan Steffel 1, Anja Hurlimann 1, Christoph Starck 2, Nazmi Krasniqi 1, Susann Schmidt 1, Thomas
More informationOLBI Stimulation in Biatrial Pacing? A Comparison of Acute Pacing and Sensing Conditions for Split Bipolar and Dual Cathodal Unipolar Configurations
236 June 1999 OLBI Stimulation in Biatrial Pacing? A Comparison of Acute Pacing and Sensing Conditions for Split Bipolar and Dual Cathodal Unipolar Configurations A. KUTARSKI, M. SCHALDACH*, M. WÓJCIK,
More informationCONTAK CD CLINICAL SUMMARY
CAUTION: Federal law restricts this device to sale by or on the order of a physician trained or experienced in device implant and follow-up procedures. CLINICAL SUMMARY CONTAK CD Boston Scientific Corporation
More informationCardiac resynchronization therapy: when and for whom?
European Heart Journal Supplements (2002)4 (Supplement D), D117-D121 Cardiac resynchronization therapy: when and for whom? Cardiothoracic Centre, Liverpool, U.K. Potential candidates for cardiac resynchronization
More informationC h a p t e r 15. Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias
C h a p t e r 15 Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias Claudia Ypenburg Lieselot van Erven Gabe B. Bleeker Jeroen
More informationAdult patients with congenital heart. Case Report
Case Report Hellenic J Cardiol 2010; 51: 178-182 Feasibility of Cardiac Resynchronization Therapy in a Patient with Complex Congenital Heart Disease and Dextrocardia, Facilitated by Cardiac Computed Tomography
More informationUnitedHealthcare Medicare Advantage Cardiology Prior Authorization Program
Electrophysiology Implant Classification Table The table below contains the codes that apply to our UnitedHealthcare Medicare Advantage cardiology prior Description Includes Generator Placement Includes
More informationRecent Advances in Pacing and Defibrillation Harish Doppalapudi, MD
Recent Advances in Pacing and Defibrillation Harish Doppalapudi, MD Harish Doppalapudi, MD Assistant Professor of Medicine Director, Clinical Cardiac Electrophysiology Training Program University of Alabama
More information